BetaThis is a new service - your feedback will help us to improve it.
Entry title:
Antimicrobial resistance in Escherichia coli (E. coli) bacteriuria
Last updated on Thursday, 31 July 2025 at 04:28pm
This page provides information on resistance to antimicrobials in Escherichia coli bacteriuria (bacteria found in urine specimens). Data breakdowns are available for England, by UKHSA Region and by Integrated Care Board.
Antibiotics are grouped based on the UK-AWaRe classification. These are:
Access Access antibiotics are with a narrow spectrum of activity, fewer side effects, lower costs, and importantly lower resistance potential. These are first or second choice antibiotics recommended for empiric treatment of the most common infections and should be widely available. That is to say, these antibiotics should offer the best therapeutic value while minimizing the potential for resistance.
Watch Watch antibiotics have a higher resistance potential and are broader-spectrum antibiotics. These are first or second choice antibiotics indicated for a limited number of infective syndromes. As these antibiotics are considered to have a higher potential for selection of AMR, their use should be carefully monitored.
Reserve Reserve antibiotics are “last resort” antibiotics, including new antibiotics. These are used for highly selected patients (life-threatening infections due to multi-drug-resistant bacteria) and are closely monitored and prioritized as targets of stewardship programmes to ensure continued effectiveness.
Resistance
Rolling monthly average percent of E. coli bacteriuria resistant to nitrofurantoin and trimethoprim. Monthly figures are shown as the first day of each month. For example, the figures for January 2022 are shown as at "1 Jan 2022".
Resistance data for rolling monthly average percent of E. coli bacteriuria resistant to nitrofurantoin and trimethoprim. Monthly figures are shown as the first day of each month. For example, the figures for January 2022 are shown as at "1 Jan 2022".
Up to and including 1 April 2025
Month
Nitrofurantoin (Access)
Trimethoprim (Access)
1 Apr 2025
1.99
30.07
1 Mar 2025
1.93
29.98
1 Feb 2025
1.91
29.98
1 Jan 2025
1.90
29.81
1 Dec 2024
1.91
29.39
1 Nov 2024
1.93
28.93
1 Oct 2024
1.95
28.72
1 Sep 2024
1.99
28.63
1 Aug 2024
2.02
28.78
1 Jul 2024
2.05
28.94
1 Jun 2024
2.08
29.28
1 May 2024
2.12
29.40
1 Apr 2024
2.12
29.25
1 Mar 2024
2.07
29.10
1 Feb 2024
2.01
28.90
1 Jan 2024
1.96
28.58
1 Dec 2023
1.90
28.00
1 Nov 2023
1.88
27.67
1 Oct 2023
1.90
27.48
1 Sep 2023
1.88
27.51
1 Aug 2023
1.95
27.62
1 Jul 2023
1.98
27.88
1 Jun 2023
2.07
28.16
1 May 2023
2.00
28.18
1 Apr 2023
1.91
28.35
1 Mar 2023
1.81
28.26
1 Feb 2023
1.74
28.21
1 Jan 2023
1.71
27.83
1 Dec 2022
1.74
27.43
1 Nov 2022
1.78
27.04
1 Oct 2022
1.78
26.68
1 Sep 2022
1.80
26.53
1 Aug 2022
1.84
26.61
1 Jul 2022
1.99
26.90
1 Jun 2022
2.14
27.32
1 May 2022
2.24
27.43
1 Apr 2022
2.28
27.32
1 Mar 2022
2.25
27.25
1 Feb 2022
2.23
27.13
1 Jan 2022
2.22
26.91
1 Dec 2021
2.21
26.52
1 Nov 2021
2.19
26.37
1 Oct 2021
2.23
26.28
1 Sep 2021
2.22
26.22
1 Aug 2021
2.35
26.50
1 Jul 2021
2.32
27.01
1 Jun 2021
2.37
27.56
1 May 2021
2.32
27.84
1 Apr 2021
2.35
27.92
1 Mar 2021
2.35
28.18
1 Feb 2021
2.32
28.23
1 Jan 2021
2.28
28.37
1 Dec 2020
2.27
28.29
1 Nov 2020
2.17
28.39
1 Oct 2020
2.09
28.75
1 Sep 2020
2.04
29.13
1 Aug 2020
2.11
29.66
1 Jul 2020
2.25
30.06
Download
About
Source: AMR module of Second Generation Surveillance System (SGSS). SGSS is a live reporting database, and therefore data is subject to change.
Note 1: The chart shows a three-month rolling average, so the data shown for one month is the average across that month and the previous two months.
Note 2: Interpreting national antibiotic resistance surveillance trends spanning European Committee on Antimicrobial Susceptibility Testing (EUCAST) clinical breakpoint transition periods requires additional consideration to avoid misinterpretation of data.
Note 3: Specimen setting was defined using fields available in SGSS AMR and Trust data available from the 2023/24 Estates Return Information Collection (ERIC). Acute Trust specimens are those recorded by the laboratory as being taken in an acute trust setting or those with site codes that matched an ‘Acute’ trust type in ERIC. GP specimens are those recorded by the laboratory as being taken at a GP surgery or those not matching a trust type in ERIC; in addition, from previous validation work, codes of non-GP sites were also excluded from the GP specimens grouping. Presentation by setting may be impacted by local laboratory data reporting, whereby laboratories that do not differentiate between specimen settings may inaccurately represent the split in Acute Trust versus GP specimen setting for that area.
Rolling monthly average number of E. coli bacteriuria tested for resistance to nitrofurantoin. Monthly figures are shown as the first day of each month. For example, the figures for January 2022 are shown as at "1 Jan 2022".
Source: AMR module of Second Generation Surveillance System (SGSS). SGSS is a live reporting database, and therefore data is subject to change.
Note 1: The chart shows a three-month rolling average, so the data shown for one month is the average across that month and the previous two months.
Note 2: Interpreting national antibiotic resistance surveillance trends spanning European Committee on Antimicrobial Susceptibility Testing (EUCAST) clinical breakpoint transition periods requires additional consideration to avoid misinterpretation of data.
Note 3: Specimen setting was defined using fields available in SGSS AMR and Trust data available from the 2023/24 Estates Return Information Collection (ERIC). Acute Trust specimens are those recorded by the laboratory as being taken in an acute trust setting or those with site codes that matched an ‘Acute’ trust type in ERIC. GP specimens are those recorded by the laboratory as being taken at a GP surgery or those not matching a trust type in ERIC; in addition, from previous validation work, codes of non-GP sites were also excluded from the GP specimens grouping. Presentation by setting may be impacted by local laboratory data reporting, whereby laboratories that do not differentiate between specimen settings may inaccurately represent the split in Acute Trust versus GP specimen setting for that area.
Testing by setting type
Rolling monthly average percent of E. coli bacteriuria tested for resistance to nitrofurantoin. Monthly figures are shown as the first day of each month. For example, the figures for January 2022 are shown as at "1 Jan 2022".
Testing by setting type data for rolling monthly average percent of E. coli bacteriuria tested for resistance to nitrofurantoin. Monthly figures are shown as the first day of each month. For example, the figures for January 2022 are shown as at "1 Jan 2022".
Up to and including 1 April 2025
Month
All settings
1 Apr 2025
91.15
1 Mar 2025
91.32
1 Feb 2025
91.58
1 Jan 2025
91.77
1 Dec 2024
91.98
1 Nov 2024
92.09
1 Oct 2024
92.25
1 Sep 2024
92.39
1 Aug 2024
92.56
1 Jul 2024
92.71
1 Jun 2024
92.76
1 May 2024
92.90
1 Apr 2024
92.95
1 Mar 2024
93.13
1 Feb 2024
93.12
1 Jan 2024
93.27
1 Dec 2023
93.35
1 Nov 2023
93.56
1 Oct 2023
93.76
1 Sep 2023
93.96
1 Aug 2023
94.06
1 Jul 2023
94.11
1 Jun 2023
94.20
1 May 2023
94.39
1 Apr 2023
94.57
1 Mar 2023
94.77
1 Feb 2023
94.86
1 Jan 2023
94.97
1 Dec 2022
95.08
1 Nov 2022
95.28
1 Oct 2022
95.52
1 Sep 2022
95.84
1 Aug 2022
96.23
1 Jul 2022
96.63
1 Jun 2022
96.93
1 May 2022
97.04
1 Apr 2022
97.04
1 Mar 2022
96.99
1 Feb 2022
96.73
1 Jan 2022
96.45
1 Dec 2021
96.23
1 Nov 2021
96.18
1 Oct 2021
96.17
1 Sep 2021
96.08
1 Aug 2021
96.05
1 Jul 2021
96.12
1 Jun 2021
96.32
1 May 2021
96.62
1 Apr 2021
96.77
1 Mar 2021
96.84
1 Feb 2021
96.92
1 Jan 2021
97.05
1 Dec 2020
97.05
1 Nov 2020
97.16
1 Oct 2020
97.31
1 Sep 2020
97.49
1 Aug 2020
97.55
1 Jul 2020
97.64
Month
GP
1 Apr 2025
90.78
1 Mar 2025
90.90
1 Feb 2025
91.16
1 Jan 2025
91.34
1 Dec 2024
91.54
1 Nov 2024
91.69
1 Oct 2024
91.83
1 Sep 2024
91.97
1 Aug 2024
92.17
1 Jul 2024
92.30
1 Jun 2024
92.36
1 May 2024
92.49
1 Apr 2024
92.52
1 Mar 2024
92.72
1 Feb 2024
92.66
1 Jan 2024
92.88
1 Dec 2023
93.00
1 Nov 2023
93.27
1 Oct 2023
93.45
1 Sep 2023
93.62
1 Aug 2023
93.72
1 Jul 2023
93.77
1 Jun 2023
93.84
1 May 2023
94.03
1 Apr 2023
94.21
1 Mar 2023
94.43
1 Feb 2023
94.53
1 Jan 2023
94.64
1 Dec 2022
94.78
1 Nov 2022
94.99
1 Oct 2022
95.24
1 Sep 2022
95.59
1 Aug 2022
96.02
1 Jul 2022
96.48
1 Jun 2022
96.77
1 May 2022
96.89
1 Apr 2022
96.92
1 Mar 2022
96.86
1 Feb 2022
96.56
1 Jan 2022
96.20
1 Dec 2021
95.96
1 Nov 2021
95.89
1 Oct 2021
95.81
1 Sep 2021
95.68
1 Aug 2021
95.59
1 Jul 2021
95.68
1 Jun 2021
95.95
1 May 2021
96.38
1 Apr 2021
96.57
1 Mar 2021
96.66
1 Feb 2021
96.76
1 Jan 2021
96.94
1 Dec 2020
96.96
1 Nov 2020
97.04
1 Oct 2020
97.14
1 Sep 2020
97.28
1 Aug 2020
97.33
1 Jul 2020
97.42
Month
Acute trusts
1 Apr 2025
89.93
1 Mar 2025
90.10
1 Feb 2025
90.47
1 Jan 2025
90.65
1 Dec 2024
90.94
1 Nov 2024
90.90
1 Oct 2024
91.12
1 Sep 2024
91.24
1 Aug 2024
91.39
1 Jul 2024
91.58
1 Jun 2024
91.61
1 May 2024
91.82
1 Apr 2024
91.92
1 Mar 2024
92.11
1 Feb 2024
92.25
1 Jan 2024
92.28
1 Dec 2023
92.38
1 Nov 2023
92.41
1 Oct 2023
92.61
1 Sep 2023
92.85
1 Aug 2023
93.04
1 Jul 2023
93.17
1 Jun 2023
93.28
1 May 2023
93.49
1 Apr 2023
93.72
1 Mar 2023
93.92
1 Feb 2023
94.09
1 Jan 2023
94.22
1 Dec 2022
94.39
1 Nov 2022
94.54
1 Oct 2022
94.76
1 Sep 2022
95.05
1 Aug 2022
95.44
1 Jul 2022
95.84
1 Jun 2022
96.18
1 May 2022
96.26
1 Apr 2022
96.21
1 Mar 2022
96.18
1 Feb 2022
96.04
1 Jan 2022
95.86
1 Dec 2021
95.60
1 Nov 2021
95.57
1 Oct 2021
95.72
1 Sep 2021
95.74
1 Aug 2021
95.82
1 Jul 2021
95.77
1 Jun 2021
95.89
1 May 2021
95.98
1 Apr 2021
96.08
1 Mar 2021
96.18
1 Feb 2021
96.30
1 Jan 2021
96.34
1 Dec 2020
96.32
1 Nov 2020
96.46
1 Oct 2020
96.74
1 Sep 2020
96.93
1 Aug 2020
96.97
1 Jul 2020
97.09
Download
About
Source: AMR module of Second Generation Surveillance System (SGSS). SGSS is a live reporting database, and therefore data is subject to change.
Note 1: The chart shows a three-month rolling average, so the data shown for one month is the average across that month and the previous two months.
Note 2: Interpreting national antibiotic resistance surveillance trends spanning European Committee on Antimicrobial Susceptibility Testing (EUCAST) clinical breakpoint transition periods requires additional consideration to avoid misinterpretation of data.
Note 3: Specimen setting was defined using fields available in SGSS AMR and Trust data available from the 2023/24 Estates Return Information Collection (ERIC). Acute Trust specimens are those recorded by the laboratory as being taken in an acute trust setting or those with site codes that matched an ‘Acute’ trust type in ERIC. GP specimens are those recorded by the laboratory as being taken at a GP surgery or those not matching a trust type in ERIC; in addition, from previous validation work, codes of non-GP sites were also excluded from the GP specimens grouping. Presentation by setting may be impacted by local laboratory data reporting, whereby laboratories that do not differentiate between specimen settings may inaccurately represent the split in Acute Trust versus GP specimen setting for that area.
Resistance by setting type
Rolling monthly average percent of E. coli bacteriuria resistant to nitrofurantoin by type of setting. Monthly figures are shown as the first day of each month. For example, the figures for January 2022 are shown as at "1 Jan 2022".
Resistance by setting type data for rolling monthly average percent of E. coli bacteriuria resistant to nitrofurantoin by type of setting. Monthly figures are shown as the first day of each month. For example, the figures for January 2022 are shown as at "1 Jan 2022".
Up to and including 1 April 2025
Month
All settings
GP
1 Apr 2025
1.99
1.88
1 Mar 2025
1.93
1.81
1 Feb 2025
1.91
1.80
1 Jan 2025
1.90
1.79
1 Dec 2024
1.91
1.81
1 Nov 2024
1.93
1.84
1 Oct 2024
1.95
1.85
1 Sep 2024
1.99
1.88
1 Aug 2024
2.02
1.91
1 Jul 2024
2.05
1.95
1 Jun 2024
2.08
1.99
1 May 2024
2.12
2.04
1 Apr 2024
2.12
2.04
1 Mar 2024
2.07
1.98
1 Feb 2024
2.01
1.90
1 Jan 2024
1.96
1.83
1 Dec 2023
1.90
1.79
1 Nov 2023
1.88
1.75
1 Oct 2023
1.90
1.77
1 Sep 2023
1.88
1.74
1 Aug 2023
1.95
1.82
1 Jul 2023
1.98
1.86
1 Jun 2023
2.07
1.96
1 May 2023
2.00
1.89
1 Apr 2023
1.91
1.79
1 Mar 2023
1.81
1.71
1 Feb 2023
1.74
1.64
1 Jan 2023
1.71
1.61
1 Dec 2022
1.74
1.63
1 Nov 2022
1.78
1.64
1 Oct 2022
1.78
1.65
1 Sep 2022
1.80
1.67
1 Aug 2022
1.84
1.71
1 Jul 2022
1.99
1.85
1 Jun 2022
2.14
2.02
1 May 2022
2.24
2.14
1 Apr 2022
2.28
2.19
1 Mar 2022
2.25
2.16
1 Feb 2022
2.23
2.12
1 Jan 2022
2.22
2.10
1 Dec 2021
2.21
2.10
1 Nov 2021
2.19
2.10
1 Oct 2021
2.23
2.16
1 Sep 2021
2.22
2.13
1 Aug 2021
2.35
2.28
1 Jul 2021
2.32
2.26
1 Jun 2021
2.37
2.35
1 May 2021
2.32
2.29
1 Apr 2021
2.35
2.27
1 Mar 2021
2.35
2.27
1 Feb 2021
2.32
2.23
1 Jan 2021
2.28
2.23
1 Dec 2020
2.27
2.18
1 Nov 2020
2.17
2.08
1 Oct 2020
2.09
1.99
1 Sep 2020
2.04
1.98
1 Aug 2020
2.11
2.07
1 Jul 2020
2.25
2.23
Month
Acute trusts
1 Apr 2025
2.22
1 Mar 2025
2.19
1 Feb 2025
2.17
1 Jan 2025
2.14
1 Dec 2024
2.15
1 Nov 2024
2.16
1 Oct 2024
2.17
1 Sep 2024
2.24
1 Aug 2024
2.26
1 Jul 2024
2.27
1 Jun 2024
2.27
1 May 2024
2.28
1 Apr 2024
2.28
1 Mar 2024
2.28
1 Feb 2024
2.27
1 Jan 2024
2.25
1 Dec 2023
2.17
1 Nov 2023
2.18
1 Oct 2023
2.20
1 Sep 2023
2.17
1 Aug 2023
2.22
1 Jul 2023
2.21
1 Jun 2023
2.29
1 May 2023
2.19
1 Apr 2023
2.15
1 Mar 2023
2.01
1 Feb 2023
1.92
1 Jan 2023
1.92
1 Dec 2022
1.99
1 Nov 2022
2.08
1 Oct 2022
2.05
1 Sep 2022
2.08
1 Aug 2022
2.10
1 Jul 2022
2.25
1 Jun 2022
2.38
1 May 2022
2.44
1 Apr 2022
2.47
1 Mar 2022
2.44
1 Feb 2022
2.46
1 Jan 2022
2.47
1 Dec 2021
2.44
1 Nov 2021
2.39
1 Oct 2021
2.40
1 Sep 2021
2.41
1 Aug 2021
2.49
1 Jul 2021
2.44
1 Jun 2021
2.42
1 May 2021
2.40
1 Apr 2021
2.49
1 Mar 2021
2.49
1 Feb 2021
2.48
1 Jan 2021
2.37
1 Dec 2020
2.45
1 Nov 2020
2.37
1 Oct 2020
2.32
1 Sep 2020
2.17
1 Aug 2020
2.19
1 Jul 2020
2.28
Download
About
Source: AMR module of Second Generation Surveillance System (SGSS). SGSS is a live reporting database, and therefore data is subject to change.
Note 1: The chart shows a three-month rolling average, so the data shown for one month is the average across that month and the previous two months.
Note 2: Interpreting national antibiotic resistance surveillance trends spanning European Committee on Antimicrobial Susceptibility Testing (EUCAST) clinical breakpoint transition periods requires additional consideration to avoid misinterpretation of data.
Note 3: Specimen setting was defined using fields available in SGSS AMR and Trust data available from the 2023/24 Estates Return Information Collection (ERIC). Acute Trust specimens are those recorded by the laboratory as being taken in an acute trust setting or those with site codes that matched an ‘Acute’ trust type in ERIC. GP specimens are those recorded by the laboratory as being taken at a GP surgery or those not matching a trust type in ERIC; in addition, from previous validation work, codes of non-GP sites were also excluded from the GP specimens grouping. Presentation by setting may be impacted by local laboratory data reporting, whereby laboratories that do not differentiate between specimen settings may inaccurately represent the split in Acute Trust versus GP specimen setting for that area.
Rolling monthly average number of E. coli bacteriuria tested for resistance to trimethoprim. Monthly figures are shown as the first day of each month. For example, the figures for January 2022 are shown as at "1 Jan 2022".
Testing by setting type data for rolling monthly average number of E. coli bacteriuria tested for resistance to trimethoprim. Monthly figures are shown as the first day of each month. For example, the figures for January 2022 are shown as at "1 Jan 2022".
Up to and including 1 April 2025
Month
All settings
1 Apr 2025
82,977.67
1 Mar 2025
87,002.00
1 Feb 2025
86,699.67
1 Jan 2025
88,914.00
1 Dec 2024
89,711.00
1 Nov 2024
91,995.67
1 Oct 2024
91,564.33
1 Sep 2024
89,521.33
1 Aug 2024
85,651.00
1 Jul 2024
84,682.67
1 Jun 2024
83,089.00
1 May 2024
83,082.67
1 Apr 2024
82,563.67
1 Mar 2024
85,599.67
1 Feb 2024
84,753.33
1 Jan 2024
86,901.33
1 Dec 2023
86,325.67
1 Nov 2023
89,808.00
1 Oct 2023
90,848.67
1 Sep 2023
89,308.67
1 Aug 2023
88,638.33
1 Jul 2023
85,662.00
1 Jun 2023
81,322.67
1 May 2023
82,209.33
1 Apr 2023
81,361.67
1 Mar 2023
85,525.00
1 Feb 2023
81,159.00
1 Jan 2023
83,695.33
1 Dec 2022
82,491.00
1 Nov 2022
87,353.33
1 Oct 2022
87,559.67
1 Sep 2022
86,409.67
1 Aug 2022
82,037.00
1 Jul 2022
79,468.33
1 Jun 2022
77,924.33
1 May 2022
80,632.67
1 Apr 2022
78,946.33
1 Mar 2022
80,720.33
1 Feb 2022
78,263.33
1 Jan 2022
81,303.33
1 Dec 2021
81,085.00
1 Nov 2021
83,481.67
1 Oct 2021
82,375.33
1 Sep 2021
82,352.67
1 Aug 2021
81,102.00
1 Jul 2021
78,364.00
1 Jun 2021
76,004.00
1 May 2021
75,511.33
1 Apr 2021
73,173.33
1 Mar 2021
70,148.67
1 Feb 2021
66,903.33
1 Jan 2021
68,528.67
1 Dec 2020
71,214.67
1 Nov 2020
73,325.33
1 Oct 2020
72,215.67
1 Sep 2020
72,260.00
1 Aug 2020
68,110.67
1 Jul 2020
62,070.33
Month
GP
1 Apr 2025
57,002.67
1 Mar 2025
60,386.67
1 Feb 2025
60,188.00
1 Jan 2025
61,713.33
1 Dec 2024
62,385.67
1 Nov 2024
64,376.00
1 Oct 2024
63,991.00
1 Sep 2024
62,441.33
1 Aug 2024
59,333.00
1 Jul 2024
58,511.67
1 Jun 2024
57,211.00
1 May 2024
57,136.33
1 Apr 2024
57,198.67
1 Mar 2024
59,865.00
1 Feb 2024
59,583.67
1 Jan 2024
61,123.67
1 Dec 2023
60,182.67
1 Nov 2023
62,386.00
1 Oct 2023
62,756.33
1 Sep 2023
61,179.33
1 Aug 2023
60,481.67
1 Jul 2023
57,716.67
1 Jun 2023
54,426.00
1 May 2023
55,228.67
1 Apr 2023
55,348.33
1 Mar 2023
58,825.00
1 Feb 2023
55,551.00
1 Jan 2023
57,205.67
1 Dec 2022
56,130.33
1 Nov 2022
59,535.00
1 Oct 2022
59,459.00
1 Sep 2022
58,312.67
1 Aug 2022
54,846.33
1 Jul 2022
52,552.00
1 Jun 2022
51,335.00
1 May 2022
53,556.67
1 Apr 2022
52,678.67
1 Mar 2022
54,071.00
1 Feb 2022
52,239.33
1 Jan 2022
54,498.67
1 Dec 2021
54,355.00
1 Nov 2021
56,153.00
1 Oct 2021
55,155.00
1 Sep 2021
55,035.67
1 Aug 2021
53,728.33
1 Jul 2021
51,068.67
1 Jun 2021
49,138.67
1 May 2021
49,189.33
1 Apr 2021
48,444.67
1 Mar 2021
46,740.00
1 Feb 2021
44,243.00
1 Jan 2021
45,225.33
1 Dec 2020
47,156.00
1 Nov 2020
48,885.67
1 Oct 2020
47,866.67
1 Sep 2020
47,992.67
1 Aug 2020
44,935.00
1 Jul 2020
40,553.67
Month
Acute trusts
1 Apr 2025
25,076.67
1 Mar 2025
25,700.00
1 Feb 2025
25,622.00
1 Jan 2025
26,290.33
1 Dec 2024
26,427.33
1 Nov 2024
26,716.00
1 Oct 2024
26,707.00
1 Sep 2024
26,261.00
1 Aug 2024
25,539.00
1 Jul 2024
25,407.33
1 Jun 2024
25,113.67
1 May 2024
25,164.67
1 Apr 2024
24,589.33
1 Mar 2024
24,942.00
1 Feb 2024
24,410.00
1 Jan 2024
24,974.33
1 Dec 2023
25,338.33
1 Nov 2023
26,500.33
1 Oct 2023
27,113.00
1 Sep 2023
27,094.33
1 Aug 2023
27,136.00
1 Jul 2023
26,934.67
1 Jun 2023
25,935.67
1 May 2023
26,003.00
1 Apr 2023
25,069.00
1 Mar 2023
25,715.33
1 Feb 2023
24,697.33
1 Jan 2023
25,567.33
1 Dec 2022
25,469.33
1 Nov 2022
26,889.00
1 Oct 2022
27,166.00
1 Sep 2022
27,160.67
1 Aug 2022
26,266.00
1 Jul 2022
26,023.33
1 Jun 2022
25,724.33
1 May 2022
26,189.67
1 Apr 2022
25,367.33
1 Mar 2022
25,731.00
1 Feb 2022
25,170.67
1 Jan 2022
25,953.33
1 Dec 2021
25,876.33
1 Nov 2021
26,423.67
1 Oct 2021
26,351.00
1 Sep 2021
26,512.33
1 Aug 2021
26,654.00
1 Jul 2021
26,624.33
1 Jun 2021
26,212.00
1 May 2021
25,689.67
1 Apr 2021
24,154.33
1 Mar 2021
22,893.67
1 Feb 2021
22,136.67
1 Jan 2021
22,741.67
1 Dec 2020
23,440.33
1 Nov 2020
23,814.67
1 Oct 2020
23,710.33
1 Sep 2020
23,613.67
1 Aug 2020
22,549.00
1 Jul 2020
20,970.33
Download
About
Source: AMR module of Second Generation Surveillance System (SGSS). SGSS is a live reporting database, and therefore data is subject to change.
Note 1: The chart shows a three-month rolling average, so the data shown for one month is the average across that month and the previous two months.
Note 2: Interpreting national antibiotic resistance surveillance trends spanning European Committee on Antimicrobial Susceptibility Testing (EUCAST) clinical breakpoint transition periods requires additional consideration to avoid misinterpretation of data.
Note 3: Specimen setting was defined using fields available in SGSS AMR and Trust data available from the 2023/24 Estates Return Information Collection (ERIC). Acute Trust specimens are those recorded by the laboratory as being taken in an acute trust setting or those with site codes that matched an ‘Acute’ trust type in ERIC. GP specimens are those recorded by the laboratory as being taken at a GP surgery or those not matching a trust type in ERIC; in addition, from previous validation work, codes of non-GP sites were also excluded from the GP specimens grouping. Presentation by setting may be impacted by local laboratory data reporting, whereby laboratories that do not differentiate between specimen settings may inaccurately represent the split in Acute Trust versus GP specimen setting for that area.
Testing by setting type
Rolling monthly average percent of E. coli bacteriuria tested for resistance to trimethoprim. Monthly figures are shown as the first day of each month. For example, the figures for January 2022 are shown as at "1 Jan 2022".
Testing by setting type data for rolling monthly average percent of E. coli bacteriuria tested for resistance to trimethoprim. Monthly figures are shown as the first day of each month. For example, the figures for January 2022 are shown as at "1 Jan 2022".
Up to and including 1 April 2025
Month
All settings
1 Apr 2025
89.84
1 Mar 2025
90.10
1 Feb 2025
90.33
1 Jan 2025
90.55
1 Dec 2024
91.02
1 Nov 2024
91.38
1 Oct 2024
91.39
1 Sep 2024
90.28
1 Aug 2024
89.18
1 Jul 2024
88.42
1 Jun 2024
88.66
1 May 2024
88.71
1 Apr 2024
88.87
1 Mar 2024
88.88
1 Feb 2024
88.91
1 Jan 2024
88.97
1 Dec 2023
89.13
1 Nov 2023
89.43
1 Oct 2023
89.60
1 Sep 2023
89.69
1 Aug 2023
89.90
1 Jul 2023
90.10
1 Jun 2023
90.33
1 May 2023
90.50
1 Apr 2023
90.75
1 Mar 2023
90.95
1 Feb 2023
91.10
1 Jan 2023
91.30
1 Dec 2022
91.33
1 Nov 2022
91.90
1 Oct 2022
92.84
1 Sep 2022
94.03
1 Aug 2022
94.97
1 Jul 2022
95.67
1 Jun 2022
96.26
1 May 2022
96.57
1 Apr 2022
96.63
1 Mar 2022
96.47
1 Feb 2022
95.99
1 Jan 2022
95.48
1 Dec 2021
95.20
1 Nov 2021
95.22
1 Oct 2021
95.35
1 Sep 2021
95.36
1 Aug 2021
95.46
1 Jul 2021
95.52
1 Jun 2021
95.63
1 May 2021
95.75
1 Apr 2021
95.72
1 Mar 2021
95.75
1 Feb 2021
95.83
1 Jan 2021
96.05
1 Dec 2020
96.17
1 Nov 2020
96.49
1 Oct 2020
96.65
1 Sep 2020
96.76
1 Aug 2020
96.59
1 Jul 2020
96.68
Month
GP
1 Apr 2025
89.61
1 Mar 2025
89.83
1 Feb 2025
90.11
1 Jan 2025
90.15
1 Dec 2024
90.57
1 Nov 2024
90.84
1 Oct 2024
90.95
1 Sep 2024
89.94
1 Aug 2024
88.99
1 Jul 2024
88.42
1 Jun 2024
88.77
1 May 2024
88.86
1 Apr 2024
89.01
1 Mar 2024
89.01
1 Feb 2024
89.01
1 Jan 2024
89.11
1 Dec 2023
89.26
1 Nov 2023
89.52
1 Oct 2023
89.61
1 Sep 2023
89.66
1 Aug 2023
89.94
1 Jul 2023
90.21
1 Jun 2023
90.55
1 May 2023
90.75
1 Apr 2023
91.01
1 Mar 2023
91.15
1 Feb 2023
91.29
1 Jan 2023
91.47
1 Dec 2022
91.52
1 Nov 2022
91.96
1 Oct 2022
92.68
1 Sep 2022
93.72
1 Aug 2022
94.58
1 Jul 2022
95.32
1 Jun 2022
95.92
1 May 2022
96.28
1 Apr 2022
96.37
1 Mar 2022
96.23
1 Feb 2022
95.70
1 Jan 2022
95.18
1 Dec 2021
94.86
1 Nov 2021
94.90
1 Oct 2021
95.04
1 Sep 2021
95.07
1 Aug 2021
95.19
1 Jul 2021
95.21
1 Jun 2021
95.32
1 May 2021
95.45
1 Apr 2021
95.45
1 Mar 2021
95.47
1 Feb 2021
95.57
1 Jan 2021
95.79
1 Dec 2020
95.99
1 Nov 2020
96.32
1 Oct 2020
96.49
1 Sep 2020
96.55
1 Aug 2020
96.46
1 Jul 2020
96.62
Month
Acute trusts
1 Apr 2025
88.32
1 Mar 2025
88.52
1 Feb 2025
88.75
1 Jan 2025
89.32
1 Dec 2024
89.95
1 Nov 2024
90.46
1 Oct 2024
90.31
1 Sep 2024
89.01
1 Aug 2024
87.59
1 Jul 2024
86.43
1 Jun 2024
86.41
1 May 2024
86.45
1 Apr 2024
86.62
1 Mar 2024
86.69
1 Feb 2024
86.81
1 Jan 2024
86.81
1 Dec 2023
87.08
1 Nov 2023
87.44
1 Oct 2023
87.78
1 Sep 2023
87.94
1 Aug 2023
88.06
1 Jul 2023
88.22
1 Jun 2023
88.30
1 May 2023
88.42
1 Apr 2023
88.64
1 Mar 2023
88.94
1 Feb 2023
89.21
1 Jan 2023
89.44
1 Dec 2022
89.58
1 Nov 2022
90.42
1 Oct 2022
91.83
1 Sep 2022
93.37
1 Aug 2022
94.53
1 Jul 2022
95.25
1 Jun 2022
95.81
1 May 2022
96.05
1 Apr 2022
96.01
1 Mar 2022
95.81
1 Feb 2022
95.45
1 Jan 2022
94.97
1 Dec 2021
94.70
1 Nov 2021
94.67
1 Oct 2021
94.80
1 Sep 2021
94.81
1 Aug 2021
94.85
1 Jul 2021
94.97
1 Jun 2021
95.10
1 May 2021
95.20
1 Apr 2021
95.16
1 Mar 2021
95.26
1 Feb 2021
95.43
1 Jan 2021
95.63
1 Dec 2020
95.57
1 Nov 2020
95.86
1 Oct 2020
96.03
1 Sep 2020
96.19
1 Aug 2020
95.82
1 Jul 2020
95.80
Download
About
Source: AMR module of Second Generation Surveillance System (SGSS). SGSS is a live reporting database, and therefore data is subject to change.
Note 1: The chart shows a three-month rolling average, so the data shown for one month is the average across that month and the previous two months.
Note 2: Interpreting national antibiotic resistance surveillance trends spanning European Committee on Antimicrobial Susceptibility Testing (EUCAST) clinical breakpoint transition periods requires additional consideration to avoid misinterpretation of data.
Note 3: Specimen setting was defined using fields available in SGSS AMR and Trust data available from the 2023/24 Estates Return Information Collection (ERIC). Acute Trust specimens are those recorded by the laboratory as being taken in an acute trust setting or those with site codes that matched an ‘Acute’ trust type in ERIC. GP specimens are those recorded by the laboratory as being taken at a GP surgery or those not matching a trust type in ERIC; in addition, from previous validation work, codes of non-GP sites were also excluded from the GP specimens grouping. Presentation by setting may be impacted by local laboratory data reporting, whereby laboratories that do not differentiate between specimen settings may inaccurately represent the split in Acute Trust versus GP specimen setting for that area.
Resistance by setting type
Rolling monthly average percent of E. coli bacteriuria resistant to trimethoprim by type of setting. Monthly figures are shown as the first day of each month. For example, the figures for January 2022 are shown as at "1 Jan 2022".
Resistance by setting type data for rolling monthly average percent of E. coli bacteriuria resistant to trimethoprim by type of setting. Monthly figures are shown as the first day of each month. For example, the figures for January 2022 are shown as at "1 Jan 2022".
Up to and including 1 April 2025
Month
All settings
GP
1 Apr 2025
30.07
29.32
1 Mar 2025
29.98
29.28
1 Feb 2025
29.98
29.31
1 Jan 2025
29.81
29.10
1 Dec 2024
29.39
28.64
1 Nov 2024
28.93
28.12
1 Oct 2024
28.72
27.91
1 Sep 2024
28.63
27.68
1 Aug 2024
28.78
27.87
1 Jul 2024
28.94
28.08
1 Jun 2024
29.28
28.59
1 May 2024
29.40
28.70
1 Apr 2024
29.25
28.53
1 Mar 2024
29.10
28.39
1 Feb 2024
28.90
28.16
1 Jan 2024
28.58
27.81
1 Dec 2023
28.00
27.22
1 Nov 2023
27.67
26.86
1 Oct 2023
27.48
26.70
1 Sep 2023
27.51
26.69
1 Aug 2023
27.62
26.87
1 Jul 2023
27.88
27.13
1 Jun 2023
28.16
27.45
1 May 2023
28.18
27.47
1 Apr 2023
28.35
27.70
1 Mar 2023
28.26
27.61
1 Feb 2023
28.21
27.53
1 Jan 2023
27.83
27.08
1 Dec 2022
27.43
26.63
1 Nov 2022
27.04
26.25
1 Oct 2022
26.68
25.87
1 Sep 2022
26.53
25.71
1 Aug 2022
26.61
25.78
1 Jul 2022
26.90
26.08
1 Jun 2022
27.32
26.49
1 May 2022
27.43
26.62
1 Apr 2022
27.32
26.60
1 Mar 2022
27.25
26.56
1 Feb 2022
27.13
26.41
1 Jan 2022
26.91
26.06
1 Dec 2021
26.52
25.68
1 Nov 2021
26.37
25.55
1 Oct 2021
26.28
25.53
1 Sep 2021
26.22
25.48
1 Aug 2021
26.50
25.80
1 Jul 2021
27.01
26.36
1 Jun 2021
27.56
26.92
1 May 2021
27.84
27.19
1 Apr 2021
27.92
27.23
1 Mar 2021
28.18
27.43
1 Feb 2021
28.23
27.51
1 Jan 2021
28.37
27.66
1 Dec 2020
28.29
27.60
1 Nov 2020
28.39
27.77
1 Oct 2020
28.75
28.16
1 Sep 2020
29.13
28.69
1 Aug 2020
29.66
29.23
1 Jul 2020
30.06
29.70
Month
Acute trusts
1 Apr 2025
31.69
1 Mar 2025
31.52
1 Feb 2025
31.50
1 Jan 2025
31.39
1 Dec 2024
31.05
1 Nov 2024
30.77
1 Oct 2024
30.52
1 Sep 2024
30.82
1 Aug 2024
30.77
1 Jul 2024
30.81
1 Jun 2024
30.72
1 May 2024
30.87
1 Apr 2024
30.84
1 Mar 2024
30.71
1 Feb 2024
30.62
1 Jan 2024
30.36
1 Dec 2023
29.74
1 Nov 2023
29.47
1 Oct 2023
29.17
1 Sep 2023
29.19
1 Aug 2023
29.13
1 Jul 2023
29.30
1 Jun 2023
29.50
1 May 2023
29.52
1 Apr 2023
29.65
1 Mar 2023
29.59
1 Feb 2023
29.64
1 Jan 2023
29.39
1 Dec 2022
29.08
1 Nov 2022
28.69
1 Oct 2022
28.37
1 Sep 2022
28.21
1 Aug 2022
28.23
1 Jul 2022
28.50
1 Jun 2022
28.97
1 May 2022
29.08
1 Apr 2022
28.72
1 Mar 2022
28.60
1 Feb 2022
28.56
1 Jan 2022
28.64
1 Dec 2021
28.24
1 Nov 2021
28.04
1 Oct 2021
27.80
1 Sep 2021
27.69
1 Aug 2021
27.85
1 Jul 2021
28.21
1 Jun 2021
28.72
1 May 2021
29.04
1 Apr 2021
29.24
1 Mar 2021
29.62
1 Feb 2021
29.57
1 Jan 2021
29.73
1 Dec 2020
29.63
1 Nov 2020
29.62
1 Oct 2020
29.89
1 Sep 2020
29.99
1 Aug 2020
30.46
1 Jul 2020
30.68
Download
About
Source: AMR module of Second Generation Surveillance System (SGSS). SGSS is a live reporting database, and therefore data is subject to change.
Note 1: The chart shows a three-month rolling average, so the data shown for one month is the average across that month and the previous two months.
Note 2: Interpreting national antibiotic resistance surveillance trends spanning European Committee on Antimicrobial Susceptibility Testing (EUCAST) clinical breakpoint transition periods requires additional consideration to avoid misinterpretation of data.
Note 3: Specimen setting was defined using fields available in SGSS AMR and Trust data available from the 2023/24 Estates Return Information Collection (ERIC). Acute Trust specimens are those recorded by the laboratory as being taken in an acute trust setting or those with site codes that matched an ‘Acute’ trust type in ERIC. GP specimens are those recorded by the laboratory as being taken at a GP surgery or those not matching a trust type in ERIC; in addition, from previous validation work, codes of non-GP sites were also excluded from the GP specimens grouping. Presentation by setting may be impacted by local laboratory data reporting, whereby laboratories that do not differentiate between specimen settings may inaccurately represent the split in Acute Trust versus GP specimen setting for that area.